The metabolic syndrome (MS) is an independent risk factor for type 2 diabetic nephropathy and accompanied by subclinical inflammation which involves immune-deriving factors. Emerging studies indicate that group 2 innate lymphoid cells (ILC2s) can regulate adipose metabolism, but much less is known about the activity of ILC2s in metabolic imbalance in obesity and diabetes. This study explored the effect of ILC2s-related molecules on the occurrence of MS in type 2 diabetic nephropathy. Thirty patients with type 2 diabetic nephropathy were included in the study; the mRNA expression of ILC2s-associated molecules from peripheral blood mononuclear cell and the correlation of the ILC2s activity and the MS-related indicators were analysed. The results indicated that the waist circumference, fasting blood glucose, systolic blood pressure, diastolic blood pressure and triglyceride in patients with simple diabetes and diabetic nephropathy were increased, and the incidence of MS was 46.67% and 86.67%, respectively. The ILC2s-associated factors RORa, T1/ST2 and IL-5/ IL-13 mRNA were increased in diabetic nephropathy. There was a positive correlation between the expression level of IL-13 or T1/ST2 mRNA and some MS indexes. In addition, the levels of plasma sTNFR, eotaxin-2 and I-309 were also increased in patients with type 2 diabetic nephropathy. It suggested that the patients with type 2 diabetic nephropathy were more likely to have multiple components of MS than those with simple type 2 diabetes mellitus, and enhanced ILC2s activity might be involved in the formation of MS in diabetic nephropathy via influencing blood pressure and lipid metabolism.
Background
Type 2 diabetes (T2D) is closely related to obesity or lipid metabolism disorder; obesity is a predictor for many metabolic diseases, which represent a significant global disease burden. Obesity coincides with a low-level chronic inflammation in metabolic tissues such as the adipose tissue, liver and muscle, which are key regulators of whole-body glucose homoeostasis [1, 2] . This obesity-related metabolic inflammation drives aspects of diseases, including ineffective insulin-mediated lowering of blood glucose that can contribute to T2D. The bidirectional interaction between the immune system and whole-body metabolism has been well recognized for many years. McPhee et al. reported that anti-inflammatory or immune-resolving factors in the gut are related to obesity and diabetes [7] . This is contrasted by solid evidence for Treg and Th2 cell responses co-operating with macrophage polarization in liver and a dipose tissue, thereby mitigating risk of obesity-induced insulin resistance and diabetes [4] . In addition, studies showed that the expression levels of chemokines IP-10, RANTES and MIP-1 were increased in type 1 diabetic animal model and caused autoreactive T cells in blood circulation migrate to autoimmune attack sites, such as IP-10 can promote the lymphocytes with CXCR3 receptor aggregation. Further, the pathogenic self-reactive Th cells are involved in the damage process of pancreatic islets [5, 6] .
Immunometabolism is at the frontier for many novel therapeutic targets to control both cell-intrinsic and wholebody metabolisms in many diseases including cancer, diabetes, obesity and sepsis among others. The bidirectional interaction between the immune system and whole-body metabolism has been well recognized for many years [7] . Via effects on adipocytes and hepatocytes, immune cells can modulate whole-body metabolism and, reciprocally, host nutrition and commensal microbiota-derived metabolites modulate immunological homoeostasis. Study for immunometabolism of type 1 diabetes indicated that immune cell types, including neutrophils, mast cells, B cells and CD8 + T cells can mediate insulin resistance. By contrast, M2 macrophages prevail in lean WAT and are involved in the maintenance of adipose tissue insulin sensitivity [2, 8] . In addition, Th2 and regulatory T cell responses have been associated with protection against insulin resistance. These studies illustrate that type 2 and anti-inflammatory responses are beneficial for the expanding adipose tissue environment and the maintenance of tissue-specific insulin sensitivity and whole-body glucose homoeostasis [8, 9] .
Group 2 innate lymphoid cells (ILC2s) are important in effect or functions for eliciting allergic inflammation, parasite defence, epithelial repair, even lipid homoeostasis [3, 10, 12] . ILC2s lack rearranged Ag-specific receptors, and although many soluble factors such as cytokines and lipid mediators can influence ILC2s, direct interaction of these cells with the microenvironment of certain diseases such as T2D and its complications, and other cells has been less explored [13] . ILC2s are dependent on GATA3 and retinoic acid receptor-related orphan receptor-a (RORa) for their development and function. Several researches have demonstrated that the ILC2s promote and induce the development of CD4 + Th2 cell-dependent immunity [14, 15] . Thus, we proposed a hypothesis that there may be ILC2s in peripheral blood which related to Th2-associated inflammation. In this study, we analysed the ILC2s-related factors in PBMC from patients with type 2 diabetic nephropathy and investigated the relationship between ILC2s and the development of type 2 diabetic nephropathy, accumulating the new information for further research on immune status in patients with type 2 diabetic nephropathy.
Methods
Study population. Thirty patients (25 males, five females; average age 54.20 years) diagnosed with type 2 diabetic nephropathy (K group), thirty newly diagnosed untreated patients with simple T2D (D group, 22 males, eight females; average age 53.86 years) from November 2013 to January 2015 at the Affiliated People's Hospital of Jiangsu University were included in this study; all the patients selected with diabetic nephropathy had developed into end-stage renal disease and had been treated with maintenance haemodialysis for more than 3 months, belong to stage 5 on glomerular filtration rate. In addition, thirty healthy volunteers (N group, 23 males and seven females, average age 51.17 years) were studied simultaneously as control. The diagnosis of diabetic nephropathy and T2D was based on commonly accepted clinical and laboratory criteria. No subject had the history of rheumatism, connective tissue disease, renal kidney disease, cancer, chronic wasting disease, primary cardiovascular disease and liver or lung disease. This study was approved by the Ethical Committee of the Affiliated People's Hospital of Jiangsu University, and written informed consent was obtained from all individuals.
Human body measurements and clinical indexes detection. Height, weight and waist circumference were measured in early morning fasting. The mercury column type sphygmomanometer was used to measure the blood pressure, three times, each time interval of 1 min, take the three times average value as a blood pressure measurement. Body mass index (BMI) calculation formula: BMI = weight/height 2 . The related biochemical indicators, such as triglyceride (TG), total cholesterol (TC), lowdensity lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), fasting plasma glucose (FBG) were analysed by clinical routine methods.
Isolation of peripheral blood mononuclear cells and quantitative real-time PCR. Peripheral blood mononuclear cells (PBMCs) were obtained from patient and healthy volunteer by standard Ficoll-Hypaque density centrifugation (HaoYang company, Tianjin, China). Total RNA was extracted from PBMC with TRIzol reagent (Invitrogen, USA). Isolated total RNA was reversed-transcribed using PrimeScript â qRT-PCR Kit (Takara Biotechnology Co., Ltd., Dalian, China) according to the manufacturer's instructions. The reverse transcript PCR and qRT-PCR were performed as described previously [16] . The sequences for the primers used are shown in Table 1 . Fold changes in the expression of each objective gene relative to b-actin were calculated based on the threshold cycle (C t ). All samples were performed in triplicate. Flow cytometric quantification of ILC2. Group 2 innate lymphoid cell population was defined as Lin-ICOS+ST2+. Heparinized venous blood was freshly obtained from patients with diabetic nephropathy, simple T2D or healthy volunteers. PBMCs were isolated by standard FicollHypaque density centrifugation, and stained with fluorescein isothiocyanated anti-human lineage (BD ebioscience company, San Diego, CA, USA), phycoerythrined antihuman ICOS (BD ebioscience company) and allophycocyanined anti-human ST2 (R & D company, USA). The isotype control antibody was used in all cases. For FACS phenotype analysis, data were acquired on an Accuri C6 (BD company, USA) and analysed with FlowJo software (TreeStar, Inc., Ashland, OR, USA).
ATP III diagnostic criteria for metabolic syndrome. ATP III diagnostic criteria for metabolic syndrome (MS) are as follows: the following five items contains three or more: (1) central obesity: waist circumference greater than or equal to 102 cm (Chinese male 90 cm) or 88 cm (Chinese female 80 cm); (2) high TG, TG ≥1.7 mmol/l; (3) low highdensity lipoprotein (HDL-C); HDL-C <1.03 mmol/l (male) or <1.3 mmol/l (female), or have received medical treatment; (4) the abnormal blood pressure: systolic pressure (SBP) ≥130 mmHg or diastolic blood pressure (DBP) ≥85 mmHg; (5) fasting blood sugar (FBG) ≥5.6 mmol/l, or have received appropriate treatment.
AAH-INF-G3 array for detecting inflammatory factors. The plasma samples from patients and healthy volunteers were used to detect 40 kinds of inflammatory factors by AAH-INF-G3 antibody chip (cat, no., S02-AAH-INF-G3; Genprice Inc, San Jose, CA, USA) according to the manufacturer's protocol, which was based on immunofluorescent antibody staining. The data were obtained using laser scanner (Innopsys, Carbonne, France) to scan fluorescence signal at 532 nm wavelength and the chip analysis software to extract the data analysis.
Statistical analysis. All statistical analysis was performed using SPSS 17.0 software (SPSS Inc., Chicago). Data were expressed as the mean AE SD in figures. Comparisons were performed using the one-way ANOVA test among three groups and unpaired Student's t-test between two groups. Pearson's correlation was used to test correlation between two continuous variables; P < 0.05 was considered to be statistically significant.
Results

Comparison of the incidence of MS and MS-related indicators in three groups of subjects under ATP III diagnostic criteria
The diabetic nephropathy group had higher waist circumference, blood glucose, SBP, DBP, MS and lower HDL-C levels compared with healthy control group. Compared to simple diabetic group, the level of SBP in diabetic nephropathy group was higher and the number of MS components was higher, while the levels of blood glucose and TG were decreased. The waist circumference, TG, FBG, SBP, DBP and the number of MS risk factors in patients with simple diabetes group were higher, while HDL-C was lower than that in healthy control group ( Table 2 ).
The percentage of ILC2s and expression levels of ILC2s-related molecules
The percentage of ILC2s in PBMC from patients with diabetic nephropathy, simple T2D and healthy volunteers was determined by flow cytometry analysis. As shown in Fig. 1 , the percentage of ILC2 (Lin-ICOS+ST2+) was significantly elevated in patients with type 2 diabetic nephropathy as compared with simple T2D or healthy volunteers. Meanwhile, the mRNA levels of ILC2s-related cytokines IL-5 and IL-13 in patients with diabetic nephropathy were significantly higher than those in healthy controls and patients with simple diabetes mellitus, especially for IL-5. The expression levels of ILC2s-associated transcription factor (RORa) and membrane receptors of IL-17RB or T1/ST2 were significantly increased in diabetic nephropathy than those in healthy controls and simple T2D mellitus. Correlation analysis showed that there was a positive correlation between the mRNA expression of RORa and T1/ST2, as well as between RORa and IL-5 or IL-13 mRNA expression, respectively (Fig. 2 ). In addition, the level of Th1 transcription factor T-bet mRNA was decreased, but Th2 cytokine IL-4 and transcription factor GATA3 expression were increased in diabetic nephropathy (Fig. 3) .
Enhanced expression of sTNFR and eotaxin-2 inflammatory cytokines in diabetic nephropathy
A total of 40 kinds of inflammatory factors were detected by AAH-INF-G3 antibody array. Our data showed that the expression levels of soluble tumour necrosis factor receptors I (sTNFRI) and II (sTNFRII), eotaxin-2 (CCL24) and I-309 were significantly increased in patients with diabetic nephropathy, compared with healthy controls and simple T2D mellitus. In addition, there was an increasing trend of IP-10 in type 2 diabetic nephropathy group (Fig. 4) .
Correlation analysis of ILC2s-related molecules or inflammatory cytokines and MS markers in patients with diabetic nephropathy
The mRNA expression level of ILC2s-related cytokines IL-13 in patients with diabetic nephropathy was The expression levels of Th1 and Th2 cytokines or transcription factors. The expression level of Th1 transcription factor T-bet was significantly decreased in type 2 diabetic nephropathy, compared with healthy controls and simple type 2 diabetes (T2D) (A). The expression levels of Th2 cytokine IL-4 were obviously increased in type 2 diabetic nephropathy (B). Increased Th2 transcription factor GATA3 in simple T2D and also had an increasing trend in type 2 diabetic nephropathy (C). *P < 0.05 and **P < 0.01. ................................................................................................................................................................ In addition, the correlation analysis also showed that the levels of plasma eotaxin-2 and I-309 in patients with type 2 diabetic nephropathy were positively correlated with the plasma levels of FBG, TG, TC, LDL-C and DBP. Simultaneously, there was a positive correlation between plasma sTNFRI/II level and plasma CRP or I-309 level in type 2 diabetic nephropathy (Fig. 6 ).
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Discussion
Type 2 diabetes is of growing concern worldwide, and obesity is a major risk factor for T2D. The obesity epidemic represents a growing threat to public health, not only in industrialized countries but also in urban centres of developing countries. Obesity significantly increases the risk for the development of T2D, cardiovascular diseases, and eventually, cancer [17] and is often associated with a state of chronic, low-grade inflammation, which contributes to tissue-specific insulin resistance and whole-body metabolic dysfunction [18] . China has become the country with the largest T2D patients population in the world,and epidemiologic studies show that 63.9% of patients with T2D are in combination with chronic kidney disease [19] . A recent study shows that high BMI itself and weight increases over time have been independently associated with increased diabetes risk. However, longitudinal patterns of changes in BMI over time in adults who have and have not developed diabetes are scarce [20] .
Previous studies of MS or diabetic kidney disease were clinical large sample survey or correlation analysis; more specific mechanism remains to be further defined. Th1/Th2 balance is of great significance to maintain the body's immune steady-state, and ILC2s were considered to be the first cells to activate Th2 immune response, to serve as a bridge between innate immunity and adaptive immunity, to amplify the damage strength of immune response of body, and at the same time to strive for time for the formation of the adaptive immune response [3, 21] . The metabolic syndrome is an independent risk factor for type 2 diabetic nephropathy and accompanied by subclinical inflammation which involves immune-deriving factors. Recently, emerging studies indicate that ILC2s can regulate adipose metabolism, but much less is known about the activity of ILC2s in metabolic imbalance in obesity and diabetes. In this study, we explored the effect of ILC2s-related molecules on the occurrence of metabolic syndrome in type 2 diabetic nephropathy. Our data showed that the waist circumference, fasting blood glucose, systolic blood pressure, diastolic blood pressure and TG in patients with simple T2D and type 2 diabetic nephropathy were increased, and the incidence of metabolic syndrome was 46.67% and 86.67%, respectively. The ILC2s frequency and ILC2s-associated factors RORa, T1/ST2 and IL-5/IL-13 mRNA were increased in PBMC from patients with diabetic nephropathy. There was a positive correlation between the expression level of IL-13 or T1/ST2 mRNA and some MS indexes. In addition, the increased IL-4 and ........................................................................................................................................................... .... decreased T-bet expression level suggested that the patients showed Th2 polarization which might be due to enhanced ILC2 activity.
Inflammation has emerged as an important player in the pathogenesis of obesity-associated metabolic dysfunction and the development of insulin resistance and T2D. The patients with diabetic kidney disease have a variety of metabolic disorders and increased levels of pro-inflammatory mediators. As found in the present study, the sTNFRI, sTNFRII, eotaxin-2 and I-309 were significantly increased in patients with type 2 diabetic nephropathy, and there was positive correlation between the plasma levels of these inflammatory factors and some indicators of metabolic syndrome. Latest evidence has also shown that the sTNFRI and sTNFRII have been associated with progression of renal failure, end-stage renal disease and mortality in early stages of chronic kidney disease, mostly in the context of diabetic nephropathy [22] . Our results were consistent with this finding, and correlation analysis further showed that the levels of plasma sTNFRII in patients with type 2 diabetic nephropathy were positively correlated with plasma CRP, and the increase in plasma CRP level was closely related to renal injury. In addition, a human chemokine ligand (I-309/ CCL1) and eotaxin-2 were also increased in type 2 diabetic nephropathy in this study, and there was a positive correlation between eotaxin-2 or I-309 and GLU, TG or DBP, respectively. Because eotaxin-2 and I-309 were associated with eosinophil chemotaxis, it was linked to the involvement of ILC2s in the progression of eosinophils in asthma and speculated that eotaxin-2 or I-309 might be related to the activity of ILC2s cells in diabetic nephropathy. Therefore, identifying the exact mechanisms and cellular and molecular players governing this immune-glycolipid metabolism crosstalk in type 2 diabetic nephropathy is of particular importance. In addition, GATA3 is also expressed in ILC2s, but not specifically, whereas RORa is a ILC2s-specific transcription factor. In this study, GATA3 was significantly higher in patients with simple T2D mellitus but not increased in patients with diabetic nephropathy.
In conclusion, the results presented in this study suggested that the incidence of metabolic syndrome was higher in type 2 diabetic nephropathy than in simple T2D or healthy volunteers. The ILC2s frequency and ILC2s-associated factors were increased in type 2 diabetic nephropathy, and there was a positive correlation between the expression level of IL-13 or T1/ST2 mRNA and some MS index. In addition, inflammatory factors, such as sTNFR, eotaxin-2 and I-309, were increased in diabetic nephropathy, which might be one of the causes of kidney damage and factors related to ILC2s activity. Our findings open a new area of research to explore that ILC2s activity and the expression levels of sTNFR, eotaxin-2 and I-309 may be considered as important factors to maintain the polarization of Th2 cells and kidney damage for early detection of patients with T2D who are at greater risk of development of nephropathy, even metabolic syndrome.
